GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gelesis Holdings GLSHQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

$25.8m

FY2020FY2022

Net income

−$57.1m

FY2020FY2022

Free cash flow

−$86.8m

FY2020FY2022

Shareholders' equity

−$25.1m

FY2020FY2022

Income statement

Fiscal years

FY2022FY2021FY2020
Revenue$25.8m$11.2m—
Research and development$18.6m$12.9m—
Operating income−$121.8m−$85.0m—
Net income−$57.1m−$93.7m−$15.3m
Diluted earnings per share-0.78-1.30-0.44

Balance sheet

At each fiscal year end

FY2022FY2021FY2020
Total assets$103.3m$146.3m$276.8m
Cash and short-term investments$7.4m$28.4m$491,827
Total liabilities$115.8m$146.3m$41.4m
Debt$62.3m$66.3m—
Shareholders' equity−$25.1m−$329.8m$235.4m
Shares outstanding73m72m35m

Cash flow

Fiscal years

FY2022FY2021FY2020
Cash from operations−$77.7m−$55.3m−$861,345
Capital spending−$9.1m−$19.9m—
Free cash flow−$86.8m−$75.2m−$861,345

Latest quarters

By quarter end

Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021
Revenue$1.1m$1.8m$2.6m$6.7m$9.0m$7.5m$2.9m$3.0m
Operating income−$10.0m−$12.0m−$26.4m−$17.9m−$34.4m−$43.1m−$20.1m−$28.3m
Net income−$7.7m−$5.2m−$24.5m−$14.2m−$12.6m−$5.8m−$19.4m−$30.8m
Diluted earnings per share-0.10-0.07-0.33-0.19-0.17-0.08-0.27-0.43
Cash from operations—−$8.0m−$16.0m−$21.0m−$4.0m−$35.0m−$28.0m$8.0m
Capital spending———−$3.0m−$3.0m−$1.0m−$1.0m−$8.0m
Free cash flow———−$24.0m−$7.0m−$36.0m−$29.0m$0
Total assets$95.9m$98.8m$103.3m$130.5m$139.0m$152.9m$146.3m$276.5m
Cash and short-term investments$7.9m$3.1m$7.4m$24.8m$25.3m$34.0m$28.4m$304,944
Debt$61.2m$60.0m$61.3m$57.4m$3.7m$2.5m$29.6m—
Shareholders' equity−$31.5m−$26.7m−$25.1m−$3.6m$5.1m$10.0m−$329.8m$231.7m

Valuation history

At each fiscal year end

FY2022
Price to sales0.0

Share price return

Finished calendar years

2025202420232022
Return900%-97%-83%-96%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.